XML 25 R12.htm IDEA: XBRL DOCUMENT
v3.25.3

Restructuring Accruals | 9 Months Ended
--- | ---
Sep. 30, 2025
Restructuring Accruals |
Restructuring Accruals | 6. Restructuring Accruals Selected information related to the restructuring accruals for the three months ended September 30, 2025 and 2024 is as follows: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | Fit to Win program | ​ | ​ | Other Restructuring | ​ | ​ | ​
​ | ​ | Employee | ​ | Asset | ​ | Other | ​ | Employee | ​ | Asset | ​ | Other | ​ | Total
​ |  | Costs | ​ | Impairment | ​ | Exit Costs |  | Costs | ​ | Impairment | ​ | Exit Costs | ​ | Restructuring
Balance at July 1, 2025 | ​ | $ | 47 | ​ | $ | ​ | ​ | $ | 31 | ​ | $ | 5 | ​ | $ | ​ | ​ | $ | 3 | ​ | $ | 86
Charges | ​ | ​ | 13 | ​ | ​ | 36 | ​ | ​ | 11 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | 60
Write-down of assets to net realizable value | ​ | ​ | ​ | ​ | ​ | (36) | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (36)
Net cash paid, principally severance and related benefits | ​ |  | (25) | ​ | ​ | ​ | ​ | ​ | (5) | ​ |  | (1) | ​ | ​ | ​ | ​ | ​ | ​ | ​ |  | (31)
Other, including foreign exchange translation | ​ |  | ​ | ​ | ​ | ​ | ​ | ​ | (2) | ​ |  | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |  | (2)
Balance at September 30, 2025 | ​ | $ | 35 | ​ | $ | — | ​ | $ | 35 | ​ | $ | 4 | ​ | $ | — | ​ | $ | 3 | ​ | $ | 77
​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | Fit to Win program | ​ | ​ | Other Restructuring | ​ | ​ | ​
​ | ​ | Employee | ​ | Asset | ​ | Other | ​ | Employee | ​ | Asset | ​ | Other | ​ | Total
​ | ​ | Costs | ​ | Impairment | ​ | Exit Costs | ​ | Costs | ​ | Impairment | ​ | Exit Costs | ​ | Restructuring
Balance at July 1, 2024 | ​ | $ | — | ​ | $ | — | ​ | $ | — | ​ | $ | 15 | ​ | $ | — | ​ | $ | 9 | ​ | $ | 24
Charges | ​ | ​ | 33 | ​ | ​ | 43 | ​ | ​ | 4 | ​ | ​ | 1 | ​ | ​ | ​ | ​ | ​ | 2 | ​ | ​ | 83
Write-down of assets to net realizable value | ​ | ​ | ​ | ​ | ​ | (43) | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (43)
Net cash paid, principally severance and related benefits | ​ |  | (1) | ​ | ​ | ​ | ​ | ​ | ​ | ​ |  | (4) | ​ | ​ | ​ | ​ | ​ | (4) | ​ |  | (9)
Other, including foreign exchange translation | ​ |  | (3) | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (1) | ​ | ​ | ​ | ​ | ​ | (3) | ​ | ​ | (7)
Balance at September 30, 2024 | ​ | $ | 29 | ​ | $ | — | ​ | $ | 4 | ​ | $ | 11 | ​ | $ | — | ​ | $ | 4 | ​ | $ | 48
​ Selected information related to the restructuring accruals for the nine months ended September 30, 2025 and 2024 is as follows: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | Fit to Win program | ​ | ​ | Other Restructuring | ​ | ​ | ​
​ | ​ | Employee | ​ | Asset | ​ | Other | ​ | Employee | ​ | Asset | ​ | Other | ​ | Total
​ | ​ | Costs | ​ | Impairment | ​ | Exit Costs | ​ | Costs | ​ | Impairment | ​ | Exit Costs | ​ | Restructuring
Balance at January 1, 2025 | ​ | $ | 51 | ​ | $ | ​ | ​ | $ | 18 | ​ | $ | 7 | ​ | $ | ​ | ​ | $ | 4 | ​ | $ | 80
Charges | ​ | ​ | 71 | ​ | ​ | 154 | ​ | ​ | 30 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | 255
Write-down of assets to net realizable value | ​ | ​ | ​ | ​ | ​ | (154) | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (154)
Net cash paid, principally severance and related benefits | ​ |  | (94) | ​ | ​ | ​ | ​ | ​ | (11) | ​ |  | (3) | ​ | ​ | ​ | ​ | ​ | (1) | ​ |  | (109)
Other, including foreign exchange translation | ​ |  | 7 | ​ | ​ | ​ | ​ | ​ | (2) | ​ |  | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |  | 5
Balance at September 30, 2025 | ​ | $ | 35 | ​ | $ | — | ​ | $ | 35 | ​ | $ | 4 | ​ | $ | — | ​ | $ | 3 | ​ | $ | 77
​ ​ ​ ​ ​ ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | Fit to Win program | ​ | ​ | Other Restructuring | ​ | ​ | ​
​ | ​ | Employee | ​ | Asset | ​ | Other | ​ | Employee | ​ | Asset | ​ | Other | ​ | Total
​ | ​ | Costs | ​ | Impairment | ​ | Exit Costs | ​ | Costs | ​ | Impairment | ​ | Exit Costs | ​ | Restructuring
Balance at January 1, 2024 | ​ | $ | — | ​ | $ | — | ​ | $ | — | ​ | $ | 27 | ​ | $ | — | ​ | $ | 12 | ​ | $ | 39
Charges | ​ | ​ | 33 | ​ | ​ | 43 | ​ | ​ | 4 | ​ | ​ | 1 | ​ | ​ | ​ | ​ | ​ | 2 | ​ | ​ | 83
Write-down of assets to net realizable value | ​ | ​ | ​ | ​ | ​ | (43) | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (43)
Net cash paid, principally severance and related benefits | ​ |  | (1) | ​ | ​ | ​ | ​ | ​ | ​ | ​ |  | (16) | ​ | ​ | ​ | ​ | ​ | (7) | ​ | ​ | (24)
Other, including foreign exchange translation | ​ |  | (3) | ​ | ​ | ​ | ​ | ​ | ​ | ​ |  | (1) | ​ | ​ | ​ | ​ | ​ | (3) | ​ | ​ | (7)
Balance at September 30, 2024 | ​ | $ | 29 | ​ | $ | — | ​ | $ | 4 | ​ | $ | 11 | ​ | $ | — | ​ | $ | 4 | ​ | $ | 48
​ When a decision is made to take restructuring actions, the Company manages and accounts for them programmatically apart from the ongoing operations of the business. Information related to major programs is presented separately, while minor initiatives are presented on a combined basis. As of September 30, 2025, the Company’s only major restructuring program was the Fit to Win initiative, which is expected to reduce redundant production capacity and begin to optimize the network, as well as streamline other cost areas, such as selling, general and administrative expenses. The Fit to Win initiative began in the second half of 2024 and is expected to last at least through 2026. Details regarding charges, payments and other changes to the Fit to Win restructuring accruals are presented in the tables above. For the three and nine months ended September 30, 2025, the Company recorded restructuring, asset impairment and related charges of approximately $60 million and $255 million (which included $104 million related to its decision to halt the MAGMA program), respectively, to Other expense, net in the Condensed Consolidated Results of Operations, of which all related to the Fit to Win program. For the three months ended September 30, 2025, these charges consisted of employee costs, such as severance and benefit-related costs, write-down of assets and other exit costs in the Americas segment ($59 million) and Europe segment ($1 million). For the nine months ended September 30, 2025, these charges consisted of employee costs, such as severance and benefit-related costs, write-down of assets and other exit costs in the Americas segment ($115 million), Europe segment ($56 million) and Retained corporate costs and other ($84 million). As of September 30, 2025, the Company has incurred cumulative charges of approximately $456 million related to the Fit to Win program. In October 2025, the Company substantially completed its discussions with certain European Works Councils related to additional indefinite or permanent capacity closures and the elimination of selling, general and administrative positions in Europe (see Note 16 for additional information). Additional restructuring charges are expected in future quarters when management completes their assessment to reduce redundant production capacity and streamline costs. Management does not yet have an estimate for the total restructuring charges to be incurred with this program, however, the total charges are expected to be material. The Company expects that the majority of the remaining cash expenditures related to the accrued employee and other exit costs will be paid out over the next several years. For the three and nine months ended September 30, 2024, the Company recorded restructuring and related charges of approximately $83 million to Other expense, net ($81 million) and Equity earnings ($2 million) on the Condensed Consolidated Results of Operations, of which $80 million related to the Fit to Win program. These charges consisted of employee costs, such as severance and benefit-related costs, write-down of assets and other exit costs in the Americas segment ($72 million) and Retained corporate costs and other ($11 million). The Company’s decisions to curtail selected production capacity have resulted in write-downs of certain long-lived assets to the extent their carrying value exceeded fair value or fair value less cost to sell. The Company classified the assumptions used to determine the fair value of the impaired assets in the period that the measurement was taken as Level 3 (third-party appraisals, where applicable) in the fair value hierarchy as set forth in the general accounting principles for fair value measurements. For the asset impairments recorded during the three and nine months ended September 30, 2025, the remaining carrying value of the impaired assets was approximately $0.

X
- References No definition available. + Details
Name: | us-gaap_RestructuringAndRelatedActivitiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 5.P.4.e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/420/tableOfContent Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1 + Details
Name: | us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration